CD40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity

Details for Australian Patent Application No. 2007248628 (hide)

Owner Regents of the University of Colorado

Inventors Haluszczak, Catherine; Sanchez, Phillip J.; Kedl, Ross

Agent Watermark

Pub. Number AU-A-2007248628

PCT Pub. Number WO2007/130493

Priority 60/842,009 05.09.06 US; 60/796,867 03.05.06 US; 60/809,821 01.06.06 US

Filing date 3 May 2007

Wipo publication date 15 November 2007

International Classifications

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

Event Publications

27 November 2008 PCT application entered the National Phase

  PCT publication WO2007/130493 Priority application(s): WO2007/130493

8 April 2010 Alteration of Name

  The name of the applicant has been altered to The Regents of the University of Colorado

13 May 2010 Corrigenda

  Change of Names(s) of Applicant(s), Section 104 - 2007 Under the name Regents of the University of Colorado, Application No. 2007248628, under INID (71), correct the applicant name to The Regents of the University of Colorado, a Body Corporate

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007248631-Gusseted carton

2007248623-FDD/TDD wireless link for UNII band